Levy, B. Et Al. 2019. Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol. CLINICAL LUNG CANCER , vol.20, no.3 .

Levy, B., Paz-Ares, L., Bennouna, J., Felip, E., Rodriguez Abreu, D., Isla, D., ... Barlesi, F.(2019). Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol. CLINICAL LUNG CANCER , vol.20, no.3.

Levy, Benjamin Et Al. "Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol," CLINICAL LUNG CANCER , vol.20, no.3, 2019

Levy, Benjamin Et Al. "Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol." CLINICAL LUNG CANCER , vol.20, no.3, 2019

Levy, B. Et Al. (2019) . "Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol." CLINICAL LUNG CANCER , vol.20, no.3.

@article{article, author={Benjamin Levy Et Al. }, title={Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol}, journal={CLINICAL LUNG CANCER}, year=2019}